126 related articles for article (PubMed ID: 12890040)
1. Psychosocial aspects of patient-activated atrial defibrillation.
Mitchell AR; Spurrell PA; Boodhoo L; Sulke N
J Cardiovasc Electrophysiol; 2003 Aug; 14(8):812-6. PubMed ID: 12890040
[TBL] [Abstract][Full Text] [Related]
2. Use of atrial defibrillators to convert atrial fibrillation at home: psychosocial aspects.
Schmitt C; Ndrepepa G
J Cardiovasc Electrophysiol; 2003 Aug; 14(8):817-8. PubMed ID: 12890041
[No Abstract] [Full Text] [Related]
3. Quality of life after use of the patient activated atrial defibrillator.
Spurrell P; Mitchell A; Kamalvand K; Sulke N
Int J Clin Pract; 2003; 57(1):30-4. PubMed ID: 12587939
[TBL] [Abstract][Full Text] [Related]
4. Improving the acceptability of the atrial defibrillator: patient-activated cardioversion versus automatic night cardioversion with and without sedation (ADSAS 2).
Boodhoo L; Mitchell A; Ujhelyi M; Sulke N
Pacing Clin Electrophysiol; 2004 Jul; 27(7):910-7. PubMed ID: 15271009
[TBL] [Abstract][Full Text] [Related]
5. Does sinus rhythm beget sinus rhythm? Long-term follow-up of the patient activated atrial defibrillator.
Spurrell P; Mitchell A; Kamalvand K; Higson M; Sulke N
Pacing Clin Electrophysiol; 2004 Feb; 27(2):175-81. PubMed ID: 14764167
[TBL] [Abstract][Full Text] [Related]
6. [Atrial defibrillator].
Jung W; Lüderitz B
Z Kardiol; 2000; 89 Suppl 3():206-14. PubMed ID: 10810804
[TBL] [Abstract][Full Text] [Related]
7. Do patients accept implantable atrial defibrillation therapy? Results from the Patient Atrial Shock Survey of Acceptance and Tolerance (PASSAT) Study.
Burns JL; Sears SF; Sotile R; Schwartzman DS; Hoyt RH; Alvarez LG; Ujhelyi MR
J Cardiovasc Electrophysiol; 2004 Mar; 15(3):286-91. PubMed ID: 15030417
[TBL] [Abstract][Full Text] [Related]
8. Long-term care of the patient with the atrial defibrillator.
Mitchell AR; Spurrell PA; Boodhoo LE; Sulke N
Am Heart J; 2004 Feb; 147(2):210-7. PubMed ID: 14760315
[TBL] [Abstract][Full Text] [Related]
9. Improving the acceptability of the atrial defibrillator for the treatment of persistent atrial fibrillation: the atrial defibrillator sedation assessment study (ADSAS).
Mitchell AR; Spurrell PA; Gerritse BE; Sulke N
Int J Cardiol; 2004 Aug; 96(2):141-5. PubMed ID: 15262026
[TBL] [Abstract][Full Text] [Related]
10. Echocardiographic changes and predictors of arrhythmia recurrence after long-term use of the atrial defibrillator.
Mitchell AR; Spurrell PA; Ahmet H; Kempson S; Higson M; Sulke N
Int J Cardiol; 2003 May; 89(1):25-31. PubMed ID: 12727002
[TBL] [Abstract][Full Text] [Related]
11. Monitoring treatment expectations in patients with an implantable cardioverter-defibrillator using the EXPECT-ICD scale.
Habibović M; Pedersen SS; van den Broek KC; Denollet J
Europace; 2014 Jul; 16(7):1022-7. PubMed ID: 24596397
[TBL] [Abstract][Full Text] [Related]
12. Sleep quality among patients treated with implantable atrial defibrillation therapy: effect of nocturnal shock delivery and psychological distress.
Serber ER; Sears SF; Sotile RO; Burns JL; Schwartzman DS; Hoyt RH; Alvarez LG; Ujhelyi MR
J Cardiovasc Electrophysiol; 2003 Sep; 14(9):960-4. PubMed ID: 12950541
[TBL] [Abstract][Full Text] [Related]
13. Is dual defibrillator better than conventional DDD pacing in brady-tachy syndrome? Results of the ICARUS Trial (Internal Cardioversion Antitachypacing and Prevention: Resource Utilization Study).
Santini M; Ricci R; Pignalberi C; Russo M; Magris B; Grovale N; De Santo T
J Interv Card Electrophysiol; 2005 Dec; 14(3):159-68. PubMed ID: 16421692
[TBL] [Abstract][Full Text] [Related]
14. Decreasing pain and anxiety associated with patient-activated atrial shock: a placebo-controlled study of adjunctive sedation with oral triazolam.
Fabian TJ; Schwartzman DS; Ujhelyi MR; Corey SE; Bigos KL; Pollock BG; Kroboth PD
J Cardiovasc Electrophysiol; 2006 Apr; 17(4):391-5. PubMed ID: 16643361
[TBL] [Abstract][Full Text] [Related]
15. Patient experiences with atrial fibrillation and treatment with implantable atrial defibrillation therapy.
Deaton C; Dunbar SB; Moloney M; Sears SF; Ujhelyi MR
Heart Lung; 2003; 32(5):291-9. PubMed ID: 14528186
[TBL] [Abstract][Full Text] [Related]
16. Internal defibrillation: where we have been and where we should be going?
Lévy S
J Interv Card Electrophysiol; 2005 Aug; 13 Suppl 1():61-6. PubMed ID: 16133857
[TBL] [Abstract][Full Text] [Related]
17. Dual defibrillator improves quality of life and decreases hospitalizations in patients with drug refractory atrial fibrillation.
Ricci R; Quesada A; Pignalberi C; Roda J; Disertori M; Capucci A; Raviele A; Santini M
J Interv Card Electrophysiol; 2004 Feb; 10(1):85-92. PubMed ID: 14739755
[TBL] [Abstract][Full Text] [Related]
18. Comparison of patient and partner quality of life and health outcomes in the first year after an implantable cardioverter defibrillator (ICD).
Dougherty CM; Fairbanks AM; Eaton LH; Morrison ML; Kim MS; Thompson EA
J Behav Med; 2016 Feb; 39(1):94-106. PubMed ID: 26345262
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of automatic nighttime atrial fibrillation shocks in patients with permanent internal atrial defibrillators.
Haffajee CI; Chaudhry GM; Casavant D; Pacetti PE
Am J Cardiol; 2002 Apr; 89(7):875-8. PubMed ID: 11909581
[No Abstract] [Full Text] [Related]
20. Atrial fibrillation: the role of atrial defibrillation.
Santini M; Ricci R
J Interv Card Electrophysiol; 2003 Oct; 9(2):229-33. PubMed ID: 14574036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
